Advertorial – Epigenetic Targets are a Rich Vein of Original Drugs
Advertorial – Kinases: The Second Wave
Markedly divergent effects of Ouabain on a Temozolomide‑resistant (T98G) vs. a Temozolomide‑sensitive (LN229) Glioblastoma cell line. Discover Oncology, 2023
